Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Non-Current Assets (2020 - 2026)

PROCEPT BioRobotics has reported Non-Current Assets over the past 7 years, most recently at $59.0 million for Q1 2026.

  • Quarterly Non-Current Assets rose 10.16% to $59.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $228.5 million through Mar 2026, up 9.14% year-over-year, with the annual reading at $57.7 million for FY2025, 10.6% up from the prior year.
  • Non-Current Assets was $59.0 million for Q1 2026 at PROCEPT BioRobotics, up from $57.7 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $59.0 million in Q1 2026 and troughed at $12.6 million in Q2 2022.
  • The 5-year median for Non-Current Assets is $52.5 million (2023), against an average of $45.7 million.
  • Year-over-year, Non-Current Assets surged 238.25% in 2022 and then decreased 3.65% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $36.7 million in 2022, then surged by 47.54% to $54.2 million in 2023, then dropped by 3.65% to $52.2 million in 2024, then grew by 10.6% to $57.7 million in 2025, then rose by 2.3% to $59.0 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Non-Current Assets are $59.0 million (Q1 2026), $57.7 million (Q4 2025), and $56.8 million (Q3 2025).